SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-10-081665
Filing Date
2010-04-12
Accepted
2010-04-12 17:20:38
Documents
3
Group Members
YORK CAPITAL MANAGEMENT GLOBAL ADVISORS, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D dsc13d.htm SC 13D 161665
2 AGREEMENT OF JOINT FILING DATED APRIL 12, 2010 dex1.htm EX-1 3723
3 DIRECTORS AND EXECUTIVE OFFICERS OF JGD MANAGEMENT CORP. dex2.htm EX-2 12355
  Complete submission text file 0001193125-10-081665.txt   179730
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-37954 | Film No.: 10745579
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 767 FIFTH AVENUE, 17TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE, 17TH FLOOR NEW YORK NY 10153 2123001300
JGD MANAGEMENT CORP /NY (Filed by) CIK: 0001012670 (see all company filings)

IRS No.: 133633324 | State of Incorp.: DE
Type: SC 13D